What they were paid
Viking Therapeutics Director Compensation Table · the one fiscal year held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $77,500 | $0 | $548,308 | $0 | $625,808 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Viking Therapeutics, Inc. DEF 14A filed April 1, 2026, accession 0001193125-26-137915, and prior-year filings. Open the filing on EDGAR.
How this board is paid
company policy · FY2025Viking Therapeutics pays directors a $50,000 cash retainer and $548,308 in Options.
Committees
FY2025 · as the proxy prints themAudit (Chair) · Compensation
The rest of the Viking Therapeutics board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Brian Lian, Ph.D | Director | $0 |
| Charles A. Rowland Jr | Independent Director | $623,308 |
| Lawson Macartney, B.V.M.S., Ph.D | Independent Director | $664,008 |
| Matthew W. Foehr | Independent Director | $598,308 |
| S. Kathryn Rouan, Ph.D | Independent Director | $672,663 |
The full Viking Therapeutics compensation record
free company briefThis page is one director within Viking Therapeutics's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat